Biochemistry & Pharmacology: Open Access
Open Access
ISSN: 2167-0501
ISSN: 2167-0501
Kasper Moller Jensen*
The development of effective antiviral agents relies not only on their potency against viral targets but also on an in-depth understanding of their pharmacokinetic properties and bioavailability. These parameters dictate the Absorption, Distribution, Metabolism and Excretion (ADME) of a drug, ultimately determining its efficacy in vivo. As viruses continue to evolve and cause significant global health challenges as seen in the case of SARS-CoV-2, hepatitis viruses and HIV the design and evaluation of novel antiviral compounds has become a critical focus in pharmaceutical research. Pharmacokinetic studies provide the necessary bridge between the promising results observed in vitro and the practical realities of achieving therapeutic levels in the human body.
Published Date: 2025-03-04; Received Date: 2025-02-03